Results 111 to 120 of about 24,588 (216)
Can acromegaly be controlled in all cases?
Abstract Acromegaly is a rare disease, due in most of the cases to a growth hormone (GH)‐secreting pituitary adenoma (PA), namely neuroendocrine tumour (PitNET). The treatment of patients with acromegaly is multimodal and multi‐step, including surgery, medical therapies, and radiotherapy.
Sabrina Chiloiro +14 more
wiley +1 more source
Abstract figure legend The β1‐adrenergic receptor is the predominant adrenergic subtype expressed on cardiac myocytes. Upon stimulation it activates downstream signalling pathways that increase the heart rate and cardiac output to meet metabolic demands.
Parham Diba +13 more
wiley +1 more source
Altered Intracellular Trafficking as a Mechanism for Prolonged Duration of G Protein-Coupled Receptor Activation. [PDF]
Kim TW +7 more
europepmc +1 more source
Dynamic Pathway Selectivity of TAS2R5 toward or Away from β-Arrestin or G Protein from Biased Agonists. [PDF]
Kim D +3 more
europepmc +1 more source
Intrinsic conformational equilibria position arrestin-2 for activation. [PDF]
Shriver TJ +6 more
europepmc +1 more source
Structure-Activity Relationships and Ligand-Dependent Arrestin Bias in μ-Opioid Receptor-Mediated ERK Activation. [PDF]
Huang L +7 more
europepmc +1 more source
PAR2-β-arrestin 2-ERK axis mediates <i>Malassezia globosa</i>-induced IL-17 response by disrupting ZO-1 in keratinocytes. [PDF]
Tang J +6 more
europepmc +1 more source

